Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
+6,771
New +$1M ﹤0.01% 1765
2025
Q4
Sell
-14,529
Closed -$1.42M 3527
2025
Q3
$1.42M Sell
14,529
-1,385
-9% -$112K ﹤0.01% 1651
2025
Q2
$1.11M Buy
15,914
+9,244
+139% +$527K ﹤0.01% 1724
2025
Q1
$331K Buy
6,670
+2,922
+78% +$185K ﹤0.01% 2535
2024
Q4
$262K Sell
3,748
-320
-8% -$26.6K ﹤0.01% 2754
2024
Q3
$428K Sell
4,068
-1,043
-20% -$122K ﹤0.01% 2264
2024
Q2
$725K Sell
5,111
-418
-8% -$48.2K ﹤0.01% 1749
2024
Q1
$617K Sell
5,529
-1,095
-17% -$130K ﹤0.01% 1872
2023
Q4
$859K Buy
6,624
+3,700
+127% +$510K ﹤0.01% 1539
2023
Q3
$477K Buy
2,924
+340
+13% +$59.8K ﹤0.01% 1809
2023
Q2
$473K Buy
2,584
+200
+8% +$28.8K ﹤0.01% 1786
2023
Q1
$318K Buy
+2,384
New +$280K ﹤0.01% 2023

Other funds holding ACLS

Mariner's ACLS Position: Q2 2026 in Review

Mariner opened a new position in Axcelis (ACLS) in Q2 2026: 6,771 shares worth $1.28M. The stake represents ﹤0.01% of the portfolio and ranks #1765 among its holdings. This is a return to the name: Mariner previously reported a position in ACLS as recently as Q3 2025.

Mariner first reported a position in ACLS in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.42M in Q3 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Mariner held 6,771 shares of Axcelis worth $1.28M as of Q2 2026.
  • Axcelis was a new Mariner position in Q2 2026.
  • Axcelis made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1765 holding.
  • Mariner first reported a position in Axcelis in Q1 2023 and has held it in 12 quarters since.
  • Mariner's Axcelis position peaked at $1.42M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.